Analysis of STERIS plc (STE)’s performance, earnings and valuation

At the time of writing, STERIS plc [STE] stock is trading at $220.86, up 2.97%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The STE shares have gain 7.78% over the last week, with a monthly amount glided 19.01%, and seem to be holding up well over a long-time horizon.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


On 1, February 2023, STERIS Declares $0.47 per share Dividend. In a post published today on Yahoo Finance, STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. The dividend is payable March 23, 2023 to shareholders of record at the close of business on February 24, 2023.

From an analyst’s perspective:

STERIS plc [NYSE: STE] stock has seen the most recent analyst activity on September 23, 2022, when Needham downgraded its rating to a Hold. Previously, Piper Sandler started tracking the stock with Overweight rating on July 14, 2022, and set its price target to $240. On April 07, 2022, Wolfe Research initiated with a Outperform rating and assigned a price target of $275 on the stock. Needham upgraded its rating to a Buy but stick to its price target of $233 on May 26, 2021. KeyBanc Capital Markets upgraded its rating to a Overweight. Robert W. Baird started tracking with a Outperform rating for this stock on September 02, 2020, and assigned it a price target of $175. In a note dated June 09, 2020, Needham initiated an Hold rating.

For the past year, the stock price of STERIS plc fluctuated between $159.21 and $255.93. Currently, Wall Street analysts expect the stock to reach $227.00 within the next 12 months. STERIS plc [NYSE: STE] shares were valued at $220.86 at the most recent close of the market. An investor can expect a potential return of 2.78% based on the average STE price forecast.

Analyzing the STE fundamentals

According to STERIS plc [NYSE:STE], the company’s sales were 1.2 billion in the recent quarter, which represents an 0.30% jump. Gross Margin for this corporation currently stands at +43.89% with Operating Margin at +13.57%, Pretax Margin comes in at +6.86%, and Net Margin reading is +5.32%.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 215.84 points at the first support level, and at 210.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 223.89, and for the 2nd resistance point, it is at 226.92.

STERIS plc [STE] reported earnings per share of $1.9 for its fiscal quarter that ended on 6/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $1.91/share, meaning a difference of -$0.01 and a surprise factor of -0.50%. By comparison, the stated earnings for the previous quarter ended on 3/30/2022 were $2.04 per share as compared to estimates of $2.02 per share, a difference of $0.02 representing a surprise of 1.00%.

Ratios To Look Out For

It is important to note that STERIS plc [NYSE:STE] has a current ratio of 2.20. As well, the Quick Ratio is 1.41, while the Cash Ratio is 0.38. Considering the valuation of this stock, the price to sales ratio is 5.18, the price to book ratio is 3.70.

Transactions by insiders

Insider trading has also been a hot topic recently, with 1 insiders purchasing 333 shares and 2 selling 1,698 shares in the past 3 months. Recent insider trading involved Majors Cary L, SVP and President, Healthcare, that happened on Dec 01 when 1600.0 shares were sold. Sr. VP, Gen Counsel, and Sec., Zangerle John Adam completed a deal on Jun 15 to sell 2659.0 shares. Meanwhile, Sr. VP, Gen Counsel, and Sec. Zangerle John Adam sold 8000.0 shares on Apr 20.